Vieser Jaime's Form 4 filing
Alaunos Therapeutics, Inc. (TCRT) · filed Jan 3, 2025
- Accession no.
- 0000950170-25-001257
- Filed
- Jan 3, 2025
- Trade date
- Dec 31, 2024
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $6.02K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Vieser JaimeCIK 0001846045 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | Common Stock | SSaleDisposed | −2,182 | $2.01 | −$4,385.82 | 26,712 | Direct | |
| Dec 31, 2024 | Common Stock | SSaleDisposed | −818 | $2.00 | −$1,636 | 25,894 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.